Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients
Condition(s):Coronary Artery Calcification; Vascular CalcificationLast Updated:October 19, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Coronary Artery Calcification; Vascular CalcificationLast Updated:October 19, 2017Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:February 6, 2012Completed
Condition(s):Congenital Heart Disease; Heart Failure; Endomyocardial FibrosisLast Updated:August 21, 2019Completed
Condition(s):Drug Drug InteractionLast Updated:May 1, 2023Completed
Condition(s):HypertensionLast Updated:December 8, 2021Unknown status
Condition(s):Kidney Failure, ChronicLast Updated:January 18, 2012Unknown status
Condition(s):Muscular Dystrophy, DuchenneLast Updated:October 23, 2023Terminated
Condition(s):HypertensionLast Updated:May 28, 2014Withdrawn
Condition(s):Transplant, LiverLast Updated:April 21, 2022Completed
Condition(s):AtherosclerosisLast Updated:August 1, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.